Professor Richard Edmondson
Professor of Gynaecological Oncology

  • Email: richard.edmondson@ncl.ac.uk
  • Telephone: +44 (0) 191 208 4432
  • Fax: +44 (0) 191 208 4301
  • Address: Northern Institute for Cancer Research
    Paul O'Gorman Building
    Medical School
    Framlington Place
    Newcastle upon Tyne
    NE2 4HH

Roles and Responsibilities

Member of NCRI gynae cancer clinical studies group
Chair of endometrial subgroup of NCR CSG

Qualifications

MBBS Newcastle upon Tyne 1992
MRCOG London 1998
MD Newcastle upon Tyne 2003

Previous Positions

Consultant Gynaecological Oncologist, Northern Gynaecological Oncology Centre, Gateshead 2004 to present
Subspecialty trainee in Gynaecolgical Oncology, Northern Gynaecological Oncology Centre, Gateshead 2002-2004
Specialist Registrar, Obstetrics & Gynaecology, Northern Deanery, 1996-2002

Memberships

British Gynae Cancer Society

Honours and Awards

Frank Stabler Award Newcastle 2001
British Gynae Cancer Society Award for oral presentation 2003

Research Interests

translational research in ovarian cancer

Funding

Principal Investigator
CRUK CTAAC. “PARAGON – a phase II study of the aromatase inhibitor arimidex in rare gynaecological cancers”. (2010)

EPSRC, PhD bursary “The role of artificial neural networks and Bayesian networks in predicting outcome in ovarian cancer” (2007)

CRUK vacation scholarship. “Exploring the therapeutic potential of PARP inhibitors in mismatch repair defective cells” Joint PI with Prof NJ Curtin (2007)

Catherine Cookson Fund, Newcastle Hospitals Special Trustees, “The role of GnRH II in ovarian cancer” (2006)

Northern Cancer Care & Research Society 1 year project grant, “Examining Met and HGF expression in ovarian cancer” (2005)

Gateshead NHS R&D project grant, “Establishing tissue microarrays of ovarian cancer” (2005)

Northern Cancer Care & Research Society project grant, “Technical support for the establishment of a translational ovarian cancer research group” (2004)

Co Investigator
CRUK BIDD. “MIND - Diffusion-weighted MRI, FDG-PET/CT and f-choline-PET/CT in the diagnosis of lymph node metastases in surgically-staged endometrial and cervical carcinoma” (PI Prof A Rockall) (2010)

CRUK BIDD. “Standardization of DWI MRI for quantitative assessment of ovarian cancer and implementation in clinical trials”. (PI Prof N DeSouza) (2010)

CRUK Clinical & Translational Programme Grant (PI AH Calvert) (2006)

CRUK “Phase II clinical trial of the PARP-1 inhibitor AG014699 as a single agent in patients with metastatic/advanced breast or ovarian cancer with known BRCA1 or 2 mutations” PI Dr ER Plummer (2006)

CRUK “Evaluation of p53 as a prognostic factor in the outcome to chemotherapy in ovarian cancer. 3 years”, TRICT committee PI AH Calvert, (2005)

Undergraduate Teaching

Lead for undergaduate teaching in womens health at Queen Elizabeth Hospital, Gateshead